Abstract:Abstract Background Chronic insomnia disorder, defined as difficulty initiating or maintaining sleep, or early morning awakening, ≥3 times/week for ≥3 months, causing daytime consequences, affects up to 45% of patients with coronary heart disease (CHD). This condition increases the risk of adverse cardiovascular outcomes and impairs quality of life, but remains undiagnosed and untreated in this patient group. Sleep has recently been recognized by the ESC and the AHA as a crucial part of cardiovascular health, highlighting the need for treatment of inadequate sleep. Cognitive-behavioral therapy for insomnia (CBT-I) is the gold standard for treating chronic insomnia, but its efficacy has not been investigated in patients with CHD without heart failure. Purpose To investigate the effects of CBT-I on chronic insomnia in patients with CHD, identify factors influencing treatment response, and potential pathophysiological and psychological correlates in terms of insomnia symptom change. We will also simulate the socioeconomic effects of the intervention prior to available outcome data. Methods We will conduct a randomized controlled trial comparing nurse-delivered, protocol-driven, group-based CBT-I over the course of five weeks (Figures 1 & 2) with sleep hygiene advice provided in a booklet as a control condition. In all, we will randomize 64 patients hospitalized with a coronary artery event during the preceding 4 years and who fulfil the diagnostic criteria for chronic insomnia. The study has power to detect a 25% absolute reduction in the primary outcome defined as no longer meeting the criteria for insomnia as assessed by the Bergen Insomnia Scale. Assessments pre-, post-intervention and at six months follow-up include insomnia diagnosis and severity, daytime symptoms (e.g., sleepiness, fatigue), anxiety, depression, metacognitions, quality of life, and blood and hair sampling for measures of inflammation, glycemic control and chronic cortisol exposure. Objective and subjective sleep variables will be assessed by actigraphy and sleep diaries. We will also interview a sample of patients as part of a qualitative study to explore their experience of treatment. A simulation of socioeconomic outcomes will be based on productivity loss and health service utilization. Results The first patient will be randomized in Q2 2024 and we expect the end of study to be Q4 2025. Results will provide new knowledge into the effects of CBT-I in patients with CHD and chronic insomnia, potentially underpinning the implementation of improved care strategies through enhanced sleep management, and may elucidate potential mechanistic pathways linking chronic insomnia and poor CVD outcomes. Conclusion Treating chronic insomnia in CHD patients requires further investigation and this will be the first trial to assess the effectiveness of CBT-I in CHD patients without heart failure. The trial will provide new insights regarding the impact of CBT-I on chronic insomnia in patients with CHD. Study overview. Overview of CBT-I intervention.

Cognitive behavioural therapy for insomnia (CBT-I) in schizophrenia and schizoaffective disorder: protocol for a randomised controlled trial

Investigating non-inferiority of internet-delivered versus face-to-face cognitive behavioural therapy for insomnia (CBT-I): a randomised controlled trial (iSleep well)

Cognitive behavioural therapy for insomnia (CBT-I) in patients with coronary heart disease: a protocol for a randomized controlled trial with six months follow-up

Digital Cognitive Behavior Therapy for Insomnia Improving Sleep Quality: a Real-World Study

Effects of e-aid cognitive behavioural therapy for insomnia (eCBTI) to prevent the transition from acute insomnia to chronic insomnia: study protocol for a randomised controlled trial

Clinical effectiveness of internet-based cognitive behavioral therapy for insomnia in routine secondary care: results of a randomized controlled trial

Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial

Evaluation of the effectiveness of cognitive-behavioural therapy for insomnia delivered by nurses and physicians for patients in primary care (the NPD study): protocol for a cluster randomised controlled trial

Digital Cognitive Behavioural Therapy for Insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being. Study protocol for a randomised controlled trial

Digital cognitive-behavioural therapy application compared with zolpidem for the treatment of insomnia: protocol for an exploratory randomised controlled trial

Acupuncture combined with cognitive-behavioural therapy for insomnia (CBT-I) in patients with insomnia: study protocol for a randomised controlled trial

Comparative effectiveness of three versions of a stepped care model for insomnia differing in the amount of therapist support in internet-delivered treatment: study protocol for a pragmatic cluster randomised controlled trial (GET Sleep)

Effectiveness of digital Cognitive-Behavioural Therapy for Insomnia in patients with musculoskeletal complaints and insomnia in primary care physiotherapy: study protocol for a randomised controlled trial

Cognitive behavioral therapy for insomnia in stable heart failure: Protocol for a randomized controlled trial

Investigating the efficacy of digital cognitive behavioural therapy in comparison to a sleep‐monitoring application via integrated diary and actigraphy: A randomised–controlled trial

The GoodNight study--online CBT for insomnia for the indicated prevention of depression: study protocol for a randomised controlled trial

Acceptability, tolerability, and potential efficacy of cognitive behavioural therapy for Insomnia Disorder subtypes defined by polysomnography: A retrospective cohort study

Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)

A randomized controlled trial of cognitive behavioral therapy for insomnia: An effective treatment for comorbid insomnia and depression.

Acceptance and commitment therapy-based behavioral intervention for insomnia: a pilot randomized controlled trial